Intuitive Surgical, Inc. (NASDAQ:ISRG) has been given an average recommendation of “Buy” by the twenty-one analysts that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $870.13.

Several brokerages have commented on ISRG. BidaskClub upgraded shares of Intuitive Surgical from a “buy” rating to a “strong-buy” rating in a research report on Friday, June 23rd. Royal Bank Of Canada boosted their price objective on shares of Intuitive Surgical from $800.00 to $950.00 and gave the stock a “sector perform” rating in a research report on Tuesday. Canaccord Genuity reiterated a “hold” rating and issued a $870.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, July 11th. Wells Fargo & Company reiterated an “outperform” rating and issued a $1,050.00 price objective (up from $1,000.00) on shares of Intuitive Surgical in a research report on Wednesday, July 12th. Finally, Zacks Investment Research lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, June 20th.

Shares of Intuitive Surgical (NASDAQ:ISRG) traded down 0.47% during mid-day trading on Tuesday, reaching $943.65. 169,539 shares of the company were exchanged. The stock has a market capitalization of $34.76 billion, a P/E ratio of 47.57 and a beta of 0.39. The stock has a 50 day moving average price of $908.65 and a 200-day moving average price of $772.09. Intuitive Surgical has a 12 month low of $610.71 and a 12 month high of $963.54.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, April 18th. The medical equipment provider reported $5.09 EPS for the quarter, topping the consensus estimate of $3.97 by $1.12. The company had revenue of $674.20 million for the quarter, compared to analyst estimates of $664.72 million. Intuitive Surgical had a net margin of 27.99% and a return on equity of 15.41%. The business’s revenue was up 13.4% on a year-over-year basis. During the same period in the previous year, the firm earned $4.42 EPS. Analysts predict that Intuitive Surgical will post $23.62 earnings per share for the current year.

In other news, VP Jamie Samath sold 490 shares of the company’s stock in a transaction dated Friday, April 21st. The shares were sold at an average price of $811.67, for a total transaction of $397,718.30. Following the completion of the transaction, the vice president now owns 48 shares of the company’s stock, valued at approximately $38,960.16. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Mark J. Meltzer sold 3,000 shares of the company’s stock in a transaction dated Monday, June 12th. The shares were sold at an average price of $887.09, for a total transaction of $2,661,270.00. Following the transaction, the senior vice president now directly owns 3,046 shares of the company’s stock, valued at approximately $2,702,076.14. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 55,306 shares of company stock valued at $46,588,332. Corporate insiders own 2.50% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Guardian Life Insurance Co. of America increased its position in Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 3 shares in the last quarter. Acropolis Investment Management LLC bought a new position in Intuitive Surgical during the first quarter worth approximately $115,000. D. Scott Neal Inc. bought a new position in Intuitive Surgical during the second quarter worth approximately $120,000. Parallel Advisors LLC increased its position in Intuitive Surgical by 10.1% in the first quarter. Parallel Advisors LLC now owns 153 shares of the medical equipment provider’s stock worth $129,000 after buying an additional 14 shares in the last quarter. Finally, Huntington National Bank increased its position in Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock worth $130,000 after buying an additional 21 shares in the last quarter. 97.53% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This news story was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://www.americanbankingnews.com/2017/07/18/intuitive-surgical-inc-isrg-receives-consensus-recommendation-of-buy-from-brokerages.html.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.